Dr. Shenoy is an infectious disease physician at Massachusetts General Hospital, where she serves as Associate Chief of the Infection Control Unit. She is an Assistant Professor of Medicine at Harvard Medical School. Her research has evaluated the clinical, operational and economic impact of competing infection control strategies for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) through clinical studies and mathematical modeling, has leveraged electronic health records for infection control surveillance, and applied machine-learning techniques to create real-time risk prediction models for Clostridium difficile infection. She collaborates with colleagues in Allergy and Immunology on research and implementation studies related to antibiotic allergy. She leads multidisciplinary efforts at MGH to reduce hospital acquired infections. Dr. Shenoy serves as Medical Director of the MGH Ebola and Other Special Pathogens Treatment Center. Dr. Shenoy is a Fellow in the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), where she is active in various committees.